Humanized antibodies that recognize beta amyloid peptide
US8128928B2 · kind B2 · utility
26Cited by
187References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 13, 2007 |
| Grant date | Mar 6, 2012 |
| Priority date | — |
| Expiry date | Aug 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.